Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 6,004,800 | 5,382,400 | 5,232,500 | 4,386,300 | 4,348,000 |
| Cost of Goods | 1,379,800 | 1,080,400 | 1,248,900 | 1,080,600 | 1,114,400 |
| Gross Profit | 4,625,000 | 4,302,000 | 3,983,600 | 3,305,700 | 3,233,600 |
| Operating Expenses | 3,091,700 | 2,553,900 | 2,294,200 | 2,408,700 | 2,087,200 |
| Operating Income | 1,534,100 | 1,748,500 | 1,690,300 | 897,600 | 1,146,800 |
| Interest Expense | 17,600 | 19,200 | 18,400 | 15,800 | 20,700 |
| Other Income | 81,600 | 38,100 | 30,100 | 34,900 | 40,400 |
| Pre-tax Income | 1,598,100 | 1,767,400 | 1,702,000 | 916,700 | 1,166,500 |
| Income Tax | 198,700 | 245,500 | 198,900 | 93,300 | 119,600 |
| Net Income Continuous | 1,399,400 | 1,521,900 | 1,503,100 | 823,400 | 1,046,900 |
| Minority Interests | -3,000 | N/A | N/A | N/A | N/A |
| Net Income | $1,402,400 | $1,521,900 | $1,503,100 | $823,400 | $1,046,900 |
| EPS Basic Total Ops | 2.31 | 2.46 | 2.41 | 1.32 | 1.68 |
| EPS Basic Continuous Ops | 2.31 | 2.46 | 2.41 | 1.32 | 1.68 |
| EPS Diluted Total Ops | 2.30 | 2.44 | 2.38 | 1.30 | 1.64 |
| EPS Diluted Continuous Ops | 2.30 | 2.44 | 2.38 | 1.30 | 1.64 |
| EPS Diluted Before Non-Recurring Items | 2.51 | 2.48 | 2.22 | 1.86 | 1.86 |
| EBITDA(a) | $1,679,000 | $1,888,100 | $1,825,100 | $1,004,800 | $1,236,100 |